Morgan Stanley Maintains Overweight on Nucor, Lowers Price Target to $170
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Carlos De Alba maintains an Overweight rating on Nucor (NYSE:NUE) but lowers the price target from $176 to $170.
September 18, 2024 | 11:50 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Morgan Stanley's analyst Carlos De Alba has maintained an Overweight rating on Nucor but has reduced the price target from $176 to $170, indicating a slightly less optimistic outlook.
The Overweight rating suggests continued confidence in Nucor's performance, but the lowered price target indicates a tempered outlook. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100